One platform molecule (Lazarus-V3). Multiple high-value indications.
| Program | Indication | Mechanism of Action | Status |
|---|---|---|---|
|
ATX-101
Lazarus-V3
|
Pancreatic (PDAC) / Ovarian | p53-R175H Structural Rescue | Lead Optimization |
|
ATX-102
Lazarus-V3
|
Soft Tissue Sarcoma / GBM | Hypoxia-Dependent p300 Blockade | Discovery |
|
ATX-103
Lazarus-V3
|
Neuroendocrine Tumors (NETs) | MEN-1/JunD Steric Shielding | Pre-Clinical Feasibility |